{
  "meta": {
    "title": "Thyroid_Tumors",
    "url": "https://brainandscalpel.vercel.app/thyroid-tumors-ee5c9c2a.html",
    "scrapedAt": "2025-11-29T18:31:50.466Z"
  },
  "questions": [
    {
      "id": 13631,
      "choices": [
        {
          "id": 54485,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary thyroid cancer </span></span></span></span></p>"
        },
        {
          "id": 54486,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular thyroid cancer</span></span></span></span></p>"
        },
        {
          "id": 54487,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary thyroid cancer</span></span></span></span></p>"
        },
        {
          "id": 54488,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anapalstic thyroid cancer</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A middle-aged male presents with a painless, slow-growing swelling in the neck. Fine needle aspiration cytology (FNAC) is performed. For which of the following thyroid cancers is FNAC least likely to provide a definitive diagnosis?</span></span></span></span></p>",
      "unique_key": "Q6583864",
      "question_audio": null,
      "question_video": null,
      "map_id": 32326,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Follicular thyroid cancer</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>cannot be useful for making a diagnosis of<strong> follicular thyroid cancer </strong>as it<strong> cannot </strong>distinguish between<strong> benign and malignant thyroid tumors. </strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FNAC cannot reliably&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">distinguish between<strong> benign and malignant follicular neoplasms </strong>because the diagnosis of <strong>follicular thyroid cancer </strong>requires evidence of<strong> vascular or capsular invasion</strong>, which<strong> cannot </strong>be assessed on<strong> aspiration cytology.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC is highly effective</strong> for diagnosing <strong>papillary thyroid cancer </strong>due to characteristic cytological features such as<strong> nuclear grooves and pseudoinclusions.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC can suggest</strong> a diagnosis of <strong>medullary thyroid </strong>cancer by demonstrating<strong> amyloid and calcitonin-rich cells</strong>; however, <strong>serum calcitonin levels and genetic testing </strong>are also <strong>important for diagnosis.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>can often suggest <strong>anaplastic thyroid cancer </strong>due to the presence of <strong>highly atypical cells and necrotic material</strong>; however, the<strong> aggressive nature of the disease </strong>often requires rapid additional<strong> diagnostic and therapeutic interventions.</strong></span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>has limitations in <strong>diagnosing follicular thyroid cancer </strong>because it requires<strong> histological evidence of capsular </strong>or <strong>vascular invasion </strong>to differentiate between<strong> benign and malignant lesions</strong>, which <strong>cannot be determined by cytology alone</strong>. </span></span></span></span></p>",
      "correct_choice_id": 54486,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16243,
      "choices": [
        {
          "id": 64932,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma </span></span></span></span></p>"
        },
        {
          "id": 64933,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hashimoto thyroiditis</span></span></span></span></p>"
        },
        {
          "id": 64934,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cancer</span></span></span></span></p>"
        },
        {
          "id": 64935,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary cancer</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fine needle aspiration cytology is not able to detect which of the following?</span></span></p>",
      "unique_key": "Q4919929",
      "question_audio": null,
      "question_video": null,
      "map_id": 32320,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Follicular cancer </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC cannot differentiate between benign follicular adenomas </strong>and <strong>follicular carcinoma </strong>due to the <strong>requirement of histologic evaluation </strong>of the <strong>capsule for invasion</strong>, which is not possible with FNAC.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Papillary carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>is usually <strong>diagnostic for papillary carcinoma </strong>due to its <strong>distinctive cytological features</strong>, including <strong>nuclear grooves </strong>and <strong>psammoma bodies</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hashimoto thyroiditis:&nbsp;</strong>FNAC can suggest this <strong>diagnosis when lymphocytes </strong>and <strong>Hurthle cells are present</strong>, indicating an <strong>autoimmune process</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary cancer:</strong> <strong>FNAC </strong>can suggest <strong>medullary carcinoma </strong>by <strong>demonstrating amyloid </strong>and <strong>calcitonin in cells</strong>, but a definitive diagnosis often requires additional tests such as serum calcitonin levels.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>FNAC is a useful tool </strong>in the <strong>initial assessment of thyroid nodules, </strong>it <strong>cannot distinguish between follicular adenoma </strong>and <strong>follicular carcinoma </strong>due to the necessity of examining capsular and vascular invasion histologically.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 1089</span></span></strong></span></span></p>",
      "correct_choice_id": 64934,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16235,
      "choices": [
        {
          "id": 64900,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Papillary carcinoma of thyroid</span></p>"
        },
        {
          "id": 64901,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Adenocarcinoma of colon</span></p>"
        },
        {
          "id": 64902,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Meningioma</span></p>"
        },
        {
          "id": 64903,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary cancer of the ovary</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Psammoma bodies are seen in all except:</span></p>",
      "unique_key": "Q6839929",
      "question_audio": null,
      "question_video": null,
      "map_id": 32314,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Adenocarcinoma of colon</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Psammoma bodies </strong>are <strong>not a common feature of colon adenocarcinomas</strong>. They are more typically <strong>associated with certain other epithelial tumors</strong>, like <strong>ovarian and thyroid papillary carcinomas</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Papillary carcinoma of thyroid:</strong> It is known to <strong>frequently have psammoma bodies</strong>, which are <strong>calcified concentric structures </strong>found within the tumor tissue.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Meningioma:</strong> This <strong>benign brain tumor </strong>often contains <strong>psammoma bodies</strong>, contributing to its <strong>classic histological appearance</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D:</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Papillary cancer of the ovary (serous cystadenoma of the ovary):</strong> Similar to <strong>papillary thyroid carcinoma</strong>, <strong>ovarian papillary tumors </strong>can also <strong>exhibit psammoma bodies</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Psammoma bodies </strong>are <strong>calcified structures </strong>often <strong>found in certain neoplasms </strong>such as <strong>papillary carcinoma </strong>of the <strong>thyroid, meningioma</strong>, <strong>papillary cancer of the ovary </strong>(serous cystadenoma of the ovary) and occasionally in mesothelioma<strong>&nbsp;</strong>but are not typically seen in <strong>adenocarcinoma of the colon</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1098</strong></span></p>",
      "correct_choice_id": 64901,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13651,
      "choices": [
        {
          "id": 54565,
          "text": "<p><span style=\"font-size:16px;\">Medullary carcinoma of the thyroid</span></p>"
        },
        {
          "id": 54566,
          "text": "<p><span style=\"font-size:16px;\">Pheochromocytoma</span></p>"
        },
        {
          "id": 54567,
          "text": "<p><span style=\"font-size:16px;\">Hirschsprung disease</span></p>"
        },
        {
          "id": 54568,
          "text": "<p><span style=\"font-size:16px;\">Pituitary adenoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is associated with loss of function mutation in RET proto-oncogene?</span></p>",
      "unique_key": "Q7152243",
      "question_audio": null,
      "question_video": null,
      "map_id": 32319,
      "difficulty_level": "difficult",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Hirschsprung disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Loss-of-function mutations in the RET proto-oncogene are associated with Hirschsprung disease, a congenital disorder characterized by the absence of ganglion cells in the distal colon, leading to bowel obstruction and megacolon. In contrast, gain-of-function mutations in the RET proto-oncogene are associated with multiple endocrine neoplasia (MEN) syndromes, including medullary carcinoma of the thyroid and pheochromocytoma. Pituitary adenomas are not linked to RET mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Explanation:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Options A and B:</strong> Gain of function mutations in RET proto-oncogene occurs in medullary thyroid carcinoma (Option A) and pheochromocytoma (Option B) as part of multiple endocrine neoplasia type 2A and 2B syndromes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D:</strong> Pituitary adenomas are typically associated with mutations in other genes such as MEN1 and are not directly linked to RET proto-oncogene mutations.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong><u>Educational Objective:</u></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Loss of function mutation in the RET proto-oncogene is associated with Hirschsprung disease, which is characterized by the absence of ganglion cells in the distal colon, leading to functional intestinal obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_N6PvER2.png\" width=\"1110\" height=\"272\"></span></p>",
      "correct_choice_id": 54567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16236,
      "choices": [
        {
          "id": 64904,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Follicular variant</span></p>"
        },
        {
          "id": 64905,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Unencapsulated</span></p>"
        },
        {
          "id": 64906,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Tall cell variant</span></p>"
        },
        {
          "id": 64907,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxyphilic (Hurthle) cell type</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following papillary thyroid carcinoma variants is not associated with aggressiveness?</span></p>",
      "unique_key": "Q2817948",
      "question_audio": null,
      "question_video": null,
      "map_id": 32315,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Follicular variant</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Follicular variant</strong>: While the <strong>follicular variant of papillary carcinoma </strong>tends to have a <strong>better prognosis </strong>compared to <strong>classical papillary carcinoma </strong>as it is less aggressive in its behavior.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B: Unencapsulated:&nbsp;Lack of encapsulation </strong>is a feature associated with <strong>increased aggressiveness in papillary carcinoma</strong>. <strong>Encapsulation </strong>can help <strong>contain the tumor </strong>and <strong>prevent its spread</strong>. So, this option matches the criteria for aggressiveness.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C: Tall cell variant:&nbsp;</strong>The tall cell variant of <strong>papillary carcinoma </strong>is associated with a <strong>more aggressive behavior </strong>compared to <strong>classical papillary carcinoma</strong>. Therefore, this option matches the criteria for aggressiveness.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D: Oxyphilic (Hurthle) cell type:&nbsp;</strong>Hurthle cell carcinoma, a <strong>variant of follicular thyroid carcinoma</strong>, is generally considered more aggressive than papillary carcinoma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The <strong>follicular variant of papillary carcinoma </strong>tends to have a <strong>better prognosis </strong>compared to <strong>classical papillary carcinoma </strong>as it is <strong>less aggressive in its behavior</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Follicular variant of papillary thyroid carcinoma (FV-PTC)</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The most common variant after classical PTC.</span></li><li><span style=\"font-size:12.0pt;\">Divided into:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Encapsulated, non-invasive</strong> → behaves very indolently, almost like a benign lesion (these are sometimes reclassified as \"NIFTP\" – non-invasive follicular thyroid neoplasm with papillary-like nuclear features).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Encapsulated, invasive</strong> → slightly increased risk, but generally still favorable prognosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Infiltrative (unencapsulated)</strong> → more aggressive, higher risk of nodal metastases.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">In general, <strong>when the term “follicular variant” is used without qualifiers, it usually refers to the encapsulated type, which is not aggressive.</strong></span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1091</strong></span></p>",
      "correct_choice_id": 64904,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16238,
      "choices": [
        {
          "id": 64912,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary carcinoma</span></span></span></span></p>"
        },
        {
          "id": 64913,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular carcinoma</span></span></span></span></p>"
        },
        {
          "id": 64914,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma</span></span></span></span></p>"
        },
        {
          "id": 64915,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic carcinoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following thyroid carcinomas originates from C-cells?</span></span></p>",
      "unique_key": "Q1177605",
      "question_audio": null,
      "question_video": null,
      "map_id": 32316,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Medullary carcinoma</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary thyroid carcinoma </strong>originates from the <strong>parafollicular C-cells of the thyroid</strong>, which <strong>produce calcitonin</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Follicular carcinoma:</strong> This <strong>carcinoma arises from follicular cells</strong>, which are responsible for <strong>synthesizing </strong>and <strong>secreting thyroid hormones</strong>, not calcitonin.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Papillary carcinoma: </strong>The most <strong>common type of thyroid cancer</strong>, also derived from <strong>follicular cells</strong>, and not from C-cells.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplastic carcinoma:</strong> A <strong>rare and highly aggressive thyroid cancer </strong>that <strong>arises from follicular cells </strong>and <strong>has a poor prognosis</strong>; it does not originate from C-cells.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary carcinoma </strong>of the <strong>thyroid is derived from C-cells</strong>, which are <strong>distinct from follicular cells </strong>that give <strong>rise to the more common papillary </strong>and <strong>follicular thyroid carcinomas</strong>. <strong>Medullary thyroid carcinoma </strong>is characterized by the <strong>production of calcitonin </strong>and may be associated with <strong>multiple endocrine neoplasia type 2 </strong>(MEN2).</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1095</span></span></strong></span></span></p>",
      "correct_choice_id": 64912,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16239,
      "choices": [
        {
          "id": 64916,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Papillary carcinoma</span></p>"
        },
        {
          "id": 64917,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Follicular carcinoma</span></p>"
        },
        {
          "id": 64918,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Medullary carcinoma</span></p>"
        },
        {
          "id": 64919,
          "text": "<p><span style=\"font-size:12.0pt;\">Anaplastic Carcinoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Hurthle cell tumor variant of which of the following tumors is:</span></p>",
      "unique_key": "Q1528431",
      "question_audio": null,
      "question_video": null,
      "map_id": 32317,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B) Follicular carcinoma</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hurthle cell tumors </strong>are a <strong>variant of follicular thyroid carcinoma</strong>. They are characterized by <strong>large cells with granular</strong>, <strong>eosinophilic cytoplasm </strong>and are often encapsulated.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;Papillary carcinoma:</strong> This is the most common type of <strong>thyroid carcinoma</strong>, but <strong>Hurthle cell tumors </strong>are not classified as <strong>papillary carcinoma.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:&nbsp;Medullary carcinoma:</strong> This type <strong>arises from parafollicular C cells</strong>, which is <strong>not related to the follicular cells </strong>that give rise to <strong>Hurthle cell tumors</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D:&nbsp;Anaplastic Carcinoma:</strong> Hurthle cell carcinoma is not a variant of Anaplastic carcinoma. Anaplastic Carcinoma is seen in old age and has the worst prognosis</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hurthle cell tumors </strong>are a <strong>variant of follicular thyroid carcinoma</strong>, which are characterized by <strong>distinctive large cells </strong>with <strong>abundant granular cytoplasm </strong>and are <strong>encapsulated</strong>. They <strong>differ from papillary </strong>and <strong>medullary thyroid carcinomas </strong>both in terms of their origin and histological appearance.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">Summary Table:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KhOh69j.png\" width=\"1327\" height=\"356\"></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1089</strong></span></p>",
      "correct_choice_id": 64917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16240,
      "choices": [
        {
          "id": 64920,
          "text": "<p><span style=\"font-size:12.0pt;\">Associated with BRAF mutation</span></p>"
        },
        {
          "id": 64921,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Psammoma body present in 50% cases</span></p>"
        },
        {
          "id": 64922,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Early metastasis with poor prognosis</span></p>"
        },
        {
          "id": 64923,
          "text": "<p><span style=\"font-size:12.0pt;\">Spreads by the lymphatic route</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">About papillary carcinoma of thyroid, all are true except:</span></p>",
      "unique_key": "Q3349935",
      "question_audio": null,
      "question_video": null,
      "map_id": 32318,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. C) Early metastasis with poor prognosis</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Although <strong>papillary thyroid carcinoma </strong>can <strong>metastasize early</strong>, particularly to <strong>regional lymph nodes</strong>, it usually maintains a <strong>good prognosis </strong>and is often curable.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">This does not worsen prognosis significantly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Even with lymph node metastasis, survival remains excellent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Distant metastasis (to lungs or bone) is rare, and when present, prognosis may be slightly worse but still much better than most other cancers.</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Associated with BRAF mutation:</strong> Papillary carcinoma of the thyroid is associated with BRAF gene mutation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Psammoma body present in 50% cases:</strong> Psammoma bodies are calcifications that are often found in papillary thyroid carcinoma but may not be present in as many as 50% of cases.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Spreads by the lymphatic route:</strong> This is <strong>true</strong>. Papillary thyroid carcinoma commonly spreads to regional lymph nodes via lymphatics.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\">This typically involves:</span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Cervical lymph nodes (neck)</span></li><li><span style=\"font-size:12.0pt;\">Jugular lymph chain</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Papillary carcinoma </strong>of the <strong>thyroid </strong>typically has a <strong>favorable prognosis</strong>, even with <strong>early lymphatic spread</strong>, <strong>contrasting </strong>with other <strong>cancers </strong>where <strong>early metastasis </strong>often correlates with a <strong>poor prognosis</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10<sup>th</sup> 1086</strong></span></p>",
      "correct_choice_id": 64922,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16244,
      "choices": [
        {
          "id": 64936,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary cancer</span></span></span></span></p>"
        },
        {
          "id": 64937,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary cancer</span></span></span></span></p>"
        },
        {
          "id": 64938,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular cancer</span></span></span></span></p>"
        },
        {
          "id": 64939,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic cancer</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most common thyroid cancer after radiation exposure is:</span></span></span></span></p>",
      "unique_key": "Q4142050",
      "question_audio": null,
      "question_video": null,
      "map_id": 32321,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Papillary cancer </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is a marked <strong>increase </strong>in the <strong>incidence of papillary carcinomas </strong>among <strong>children </strong>exposed to <strong>ionizing radiation </strong>(particularly during the first 2 decades of life).</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of dietary iodine </strong>(and so, goiter) is <strong>linked with a higher frequency </strong>of <strong>follicular carcinomas</strong>.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Exposure to ionizing radiation</strong>, especially during the <strong>first two decades of life</strong>, significantly <strong>increases the risk of developing papillary thyroid carcinoma</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary cancer:</strong> Medullary thyroid cancer <strong>arises from parafollicular C-cells </strong>and is typically associated with <strong>genetic mutations in the RET proto-oncogene</strong>, not with radiation exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Follicular cancer:</strong> While <strong>not </strong>associated with <strong>radiation exposure</strong>, the incidence of follicular carcinoma is higher in areas with iodine deficiency.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anaplastic cancer:</strong> Anaplastic thyroid cancer is a <strong>rare and aggressive form of thyroid cancer </strong>that generally <strong>occurs in the elderly population </strong>and is not associated with radiation exposure.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Papillary thyroid carcinoma </strong>is the <strong>most common thyroid cancer </strong>associated with <strong>childhood exposure </strong>to <strong>ionizing radiation</strong>, which can significantly <strong>increase the risk of this cancer</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1086</span></span></strong></span></span></p>",
      "correct_choice_id": 64936,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16245,
      "choices": [
        {
          "id": 64940,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Papillary carcinoma thyroid</span></p>"
        },
        {
          "id": 64941,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Carcinoma pituitary</span></p>"
        },
        {
          "id": 64942,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Paraganglioma</span></p>"
        },
        {
          "id": 64943,
          "text": "<p><span style=\"font-size:12.0pt;\">Meningioma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Orphan Annie eye nuclei appearance is characteristic of:</span></p>",
      "unique_key": "Q1308372",
      "question_audio": null,
      "question_video": null,
      "map_id": 32322,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A) Papillary carcinoma thyroid</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">This <strong>thyroid cancer </strong>is noted for its <strong>unique nuclear features</strong>, which include <strong>enlarged, overlapping nuclei </strong>with <strong>finely dispersed chromatin giving an \"empty\" appearance</strong>, also known as <strong>'Orphan Annie eye' nuclei</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/23/screenshot-2024-04-23-094905.png\" alt=\"\" width=\"300\" height=\"211\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>'Orphan Annie eye' nuclei </strong>is a <strong>distinctive cytological feature </strong>of <strong>papillary carcinoma </strong>of the <strong>thyroid</strong>, which is important for diagnosis and distinguishing it from other neoplasms.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Robbins 10th 1087</strong></span></p>",
      "correct_choice_id": 64940,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16250,
      "choices": [
        {
          "id": 64960,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MEN I</span></span></span></span></p>"
        },
        {
          "id": 64961,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MEN II</span></span></span></span></p>"
        },
        {
          "id": 64962,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fraumeni syndrome</span></span></span></span></p>"
        },
        {
          "id": 64963,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hashimoto&rsquo;s thyroiditis</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary carcinoma of the thyroid is associated with which of the following syndrome:</span></span></p>",
      "unique_key": "Q7296579",
      "question_audio": null,
      "question_video": null,
      "map_id": 32324,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) MEN II </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MEN II syndrome </strong>includes <strong>medullary thyroid carcinoma </strong>(MTC), <strong>pheochromocytoma</strong>, and <strong>parathyroid adenomas </strong>or <strong>hyperplasia. MEN II </strong>is further divided into <strong>MEN IIA </strong>(Sipple syndrome) and <strong>MEN IIB</strong>, with both subtypes having a strong association with MTC.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MEN I &ndash; Incorrect.</strong> MEN I typically involves <strong>tumors of the parathyroid glands</strong>, <strong>pituitary gland</strong>, and <strong>pancreas</strong>, not medullary thyroid carcinoma.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Li-Fraumeni syndrome &ndash; Incorrect.</strong> This is a <strong>hereditary cancer syndrome </strong>associated with a <strong>variety of cancers</strong>, including sarcomas, breast cancer, and brain tumors, but not specifically medullary thyroid carcinoma.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D:</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hashimoto&rsquo;s thyroiditis &ndash; Incorrect.</strong> This is an <strong>autoimmune disease </strong>of the <strong>thyroid gland </strong>and is not directly associated with <strong>medullary thyroid carcinoma</strong>, although thyroid cancer can occur more frequently in the setting of Hashimoto&#39;s thyroiditis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary thyroid carcinoma </strong>is commonly associated with <strong>Multiple Endocrine Neoplasia type II </strong>(MEN II), which includes <strong>two subtypes</strong>, <strong>MEN IIA </strong>and <strong>MEN IIB</strong>, both characterized by the <strong>occurrence of medullary thyroid carcinoma</strong> and p<strong>heochromocytomas</strong>. MEN IIA also includes parathyroid adenomas or hyperplasia.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1129</span></span></strong></span></span></p>",
      "correct_choice_id": 64961,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16252,
      "choices": [
        {
          "id": 64968,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary </span></span></span></span></p>"
        },
        {
          "id": 64969,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular</span></span></span></span></p>"
        },
        {
          "id": 64970,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary </span></span></span></span></p>"
        },
        {
          "id": 64971,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman with a family history of endocrine neoplasia presents with a thyroid nodule. Histological examination of the nodule after fine-needle aspiration biopsy reveals amyloid deposition. Which of the following types of thyroid carcinoma is the woman most likely to have?</span></span></p>",
      "unique_key": "Q9507210",
      "question_audio": null,
      "question_video": null,
      "map_id": 32325,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Medullary </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Originates </strong>from the <strong>parafollicular C-cells </strong>of the <strong>thyroid </strong>and is associated with <strong>amyloid deposition</strong>, which is derived from <strong>calcitonin </strong>produced by <strong>tumor cells</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Papillary carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the <strong>most common type of thyroid cancer </strong>and is characterized by <strong>branching papillae </strong>and often presents with <strong>psammoma bodies</strong>. It is not typically associated with amyloid deposition.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Follicular carcinoma</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It does <strong>not </strong>characteristically <strong>involve amyloid deposition</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Anaplastic carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>highly aggressive </strong>and <strong>undifferentiated form of thyroid cancer</strong>. Amyloid is not a feature of anaplastic thyroid carcinoma.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Medullary thyroid carcinoma </strong>is <strong>unique </strong>among <strong>thyroid cancers </strong>as it <strong>originates from parafollicular C-cells </strong>and is associated with <strong>amyloid deposition </strong>within the <strong>tumor</strong>, which can be identified histologically. This <strong>type of carcinoma </strong>can occur <strong>sporadically </strong>or as <strong>part of the multiple endocrine neoplasia type 2 syndromes.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1091</span></span></strong></span></span></p>",
      "correct_choice_id": 64970,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16256,
      "choices": [
        {
          "id": 64984,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma of thyroid</span></span></span></span></p>"
        },
        {
          "id": 64985,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoma breast</span></span></span></span></p>"
        },
        {
          "id": 64986,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adenocarcinoma lung</span></span></span></span></p>"
        },
        {
          "id": 64987,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular carcinoma of thyroid</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 47-year-old woman presents with a solitary thyroid nodule. Fine needle aspiration cytology (FNAC) is performed, and the pathologist reports that the distinction between a benign and a malignant lesion cannot be made with certainty. Which type of thyroid nodule is most notorious for requiring histologic examination beyond FNAC to establish a definitive diagnosis?</span></span></p>",
      "unique_key": "Q5883209",
      "question_audio": null,
      "question_video": null,
      "map_id": 32312,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Follicular carcinoma of thyroid</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>FNAC </strong>cannot distinguish <strong>between follicular adenoma</strong> and <strong>follicular carcinoma </strong>because the <strong>diagnosis of carcinoma depends on the identification of capsular and/or vascular invasion,</strong> which requires histologic examination of the surgical specimen.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Papillary carcinoma of thyroid</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Papillary carcinoma typically shows <strong>distinctive nuclear features on FNAC </strong>which are usually diagnostic, making it sufficient for diagnosis.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Carcinoma breast</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: FNAC can be <strong>diagnostic for breast carcinoma,</strong> showing <strong>malignant cells</strong>, but a core biopsy is often preferred for additional architectural and immunohistochemical information.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Adenocarcinoma lung</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While <strong>FNAC</strong> can suggest <strong>adenocarcinoma of the lung</strong> by demonstrating <strong>malignant glandular cells, </strong>a core biopsy is usually required for complete characterization.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>FNAC </strong>can suggest <strong>follicular neoplasm</strong>, it <strong>cannot differentiate follicular carcinoma </strong>from <strong>follicular adenoma</strong> as the <strong>latter requires the identification of capsular </strong>or <strong>vascular invasion,</strong> which necessitates histological examination of the entire surgical specimen.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1089</span></span></strong></span></span></p>",
      "correct_choice_id": 64987,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16257,
      "choices": [
        {
          "id": 64988,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Papillary carcinoma</span></span></span></span></p>"
        },
        {
          "id": 64989,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular carcinoma</span></span></span></span></p>"
        },
        {
          "id": 64990,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Medullary carcinoma</span></span></span></span></p>"
        },
        {
          "id": 64991,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anaplastic carcinoma</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old female presents to her primary care physician with a history of a progressively enlarging neck mass over the past several years. She reports no symptoms of dysphagia, dyspnea, or hoarseness. Physical examination reveals a palpable, non-tender, firm mass in the anterior neck consistent with a long-standing goitre. Which malignancy develops in long standing goitre?</span></span></p>",
      "unique_key": "Q4004384",
      "question_audio": null,
      "question_video": null,
      "map_id": 32313,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Follicular carcinoma </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It&#39;s more commonly associated with <strong>iodine deficiency</strong> and can <strong>arise in the setting of a long-standing goiter.</strong> It <strong>requires a full histological evaluation </strong>to distinguish it from <strong>benign follicular adenomas.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Papillary carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is the <strong>most common thyroid malignancy </strong>and can occur <strong>with or without a preceding goiter</strong>. It has a distinctive histological appearance but is not particularly associated with iodine deficiency or long-standing goiters.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Medullary carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This type of <strong>cancer arises from parafollicular C cells </strong>producing <strong>calcitonin</strong> and is commonly associated with <strong>genetic syndromes like MEN 2,</strong> rather than long-standing goiters.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Anaplastic carcinoma:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>very aggressive form of thyroid cancer</strong> that can <strong>arise de novo </strong>or from <strong>existing well-differentiated tumors</strong> but isn&#39;t specifically linked to long-standing goiters.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Follicular carcinoma of the <strong>thyroid is associated with iodine deficiency </strong>and is more likely to <strong>develop in the setting of a long-standing goiter</strong>. This <strong>malignancy</strong> is <strong>notorious for hematogenous spread</strong> and requires thorough <strong>histological examination</strong> to differentiate it from benign conditions.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10<sup>th</sup> 1089</span></span></strong></span></span></p>",
      "correct_choice_id": 64989,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16276,
      "choices": [
        {
          "id": 65064,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperthyroidism </span></span></span></span></p>"
        },
        {
          "id": 65065,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 65066,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Painless </span></span></span></span></p>"
        },
        {
          "id": 65067,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Giant cell on histological examination</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the following are feature of granulomatous thyroiditis except:</span></span></span></span></p>",
      "unique_key": "Q8998634",
      "question_audio": null,
      "question_video": null,
      "map_id": 32323,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Painless </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Painless Granulomatous thyroiditis,</strong> also known as <strong>subacute thyroiditis</strong> or <strong>De Quervain&#39;s thyroiditis, </strong>is typically a <strong>painful condition.</strong> It presents with a <strong>tender, swollen thyroid gland</strong> and is often <strong>preceded by an upper respiratory tract infection.</strong> <strong>Pain in the neck,</strong> <strong>jaw,</strong> or ear is a <strong>common feature,</strong> and tenderness is elicited on palpation of the gland.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; In the <strong>initial phase of granulomatous</strong> (subacute) <strong>thyroiditis</strong>, there may be a <strong>transient hyperthyroid phase</strong> due to the <strong>inflammatory destruction of thyroid follicles </strong>leading to the <strong>release of preformed thyroid hormones into circulation</strong>.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Following the <strong>hyperthyroid phase </strong>of <strong>granulomatous thyroiditis, </strong>there is a <strong>hypothyroid phase </strong>as the <strong>damaged thyroid</strong> may be <strong>temporarily unable to produce sufficient hormones</strong>. This is usually self-limited, and normal thyroid function often returns, but some patients may develop permanent hypothyroidism.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; <strong>Granulomatous thyroiditis </strong>is characterized <strong>histologically </strong>by<strong> granuloma formation with giant cells</strong>. These <strong>multinucleated giant cells </strong>are part of the<strong> body&#39;s response to inflammation </strong>and are involved in the <strong>degradation of thyroglobulin,</strong> which is released during the follicular destruction.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Granulomatous thyroiditis</strong> is the most common cause of <strong>thyroid pain, </strong>not a painless condition. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Robbins 10th 1093</span></span></strong></span></span></p>",
      "correct_choice_id": 65066,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}